Cases suffering from early- onset bone cancer have served from a new cooperation blazoned by the Ministry of Health through the National Hospital Insurance Fund( NHIF).
The Ministry of Health formed a new cooperation with Roche, a Swiss pharmaceutical company, to insure Kenyans admit standard care treatment.
READ ALSO: Unlawful acts during elections that can land you to to jail
Cases will now admit a free force of a cancer medicine treatment called Herceptin subcutaneous injection.
The medicine is a targeted anticancer remedy that’s given to adult cases who have early stage bone cancer.
NHIF cardholders with bone cancer will be eligible for the 18- cycle treatment with noco-pays or fiscal scores.
Treatment and care for terminal ails, which affect both men and women, imposes a significant fiscal and cerebral burden on cases, driving numerous Kenyans into poverty.
The Health Ministry wants to raise mindfulness about early opinion and get to a point where it can comfortably control the growing complaint.
READ ALSO: New TSC Qualifications for Primary Teachers to teach in junior secondary
